Survey of haemolytic-uraemic syndrome in Queensland 1979-1995.
OBJECTIVE
To review the clinical course of haemolytic-uraemic syndrome (HUS) in children admitted to Brisbane children's hospitals between April 1979 and October 1995.


METHODS
Retrospective case survey.


METHODS
Royal Children's Hospital and Mater Misericordiae Children's Hospital (the two major children's hospitals in Brisbane).


METHODS
All children hospitalised for HUS.


METHODS
Clinical and laboratory features on presentation (including typical [diarrhoea-positive, D+] or atypical [diarrhoea-negative, D-] presentation), clinical course, treatment and features on subsequent outpatient follow-up (1, 3, 6 and 12 months later), renal outcome on long term follow-up (3-16 years later).


RESULTS
55 children (aged 2 months to 13 years) were hospitalised for HUS, but no epidemic was detected. Seven children (13%) had D- presentations, including three (5%) with T-activation caused by pneumococcal pneumonia. Thrombocytopenia was more severe and prolonged in D- patients (P < 0.01). Major complications occurred only in the D+ group (one patient died, and two had recurrences). Chronic renal failure was significantly more likely in patients with prolonged oliguria or hypertension in the acute illness and proteinuria or hypertension on follow-up.


CONCLUSIONS
The clinical course and outcome in childhood HUS vary greatly and D- HUS is not invariably associated with a poorer prognosis than D+ HUS. Pneumococcal-associated T-activation is an important cause of D- HUS and should be actively sought to allow for appropriate therapy.
Mizusawa
Y
Y
Royal Children's Hospital, Brisbane, QLD.
Pitcher
L A
LA
Burke
J R
JR
Falk
M C
MC
Mizushima
W
W
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007223:Infant; D008297:Male; D011379:Prognosis; D011793:Queensland; D012008:Recurrence; D012189:Retrospective Studies